信息搜索
信息关键字:药
 
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·6月30日柳药集团(603368)龙虎榜数据:机构净买入1.32亿元,北向资金净卖出1707.91万元2023-6-30 18:07:27
·6月30日柳药集团涨停分析:医药商业,广西,新冠疫苗概念热股2023-6-30 16:55:48
·柳药集团今日涨停 三机构净买入1.82亿元2023-6-30 16:55:44
·医药生物行业点评报告:“十四五”大型医用设备配置规划出台,高端影像设备、手术机器人等板块有望显著受益2023-6-30 16:26:48
·美批准售台价值高达4.4亿美元弹药和提供后勤保障支持,中方回应2023-6-30 15:39:43
·医药行业2023年中期投资策略:医药仍有结构性机会,聚焦“创新+出海、复苏后半程、中特估”三条主线2023-6-30 12:54:07
·泓博医药:公司选购的GPU为英伟达A8002023-6-30 12:15:25
·泰格医药(300347)6月29日主力资金净买入1088.43万元2023-6-30 10:55:27
·中药板块盘初冲高2023-6-30 9:35:14
·奥翔药业(603229)6月29日主力资金净卖出289.43万元2023-6-30 9:03:57
·科伦药业:联合开发的创新药物TROP2抗体偶联药物被纳入突破性疗法认定名单2023-6-30 8:25:23
·银河证券:2023年下半年医药行业投资前瞻,医改政策将继续重塑医药行业生态 2023-6-30 8:17:03
·龙津药业:子公司拟向柔以时增资3000万元2023-6-30 0:55:52
·石药集团:与辉瑞签署战略合作协议2023-6-29 23:19:11
·倍益康近期取得2项四川省药品监督管理局颁发的《医疗器械注册证》2023-6-29 23:15:57
·恒瑞医药:获得磷酸瑞格列汀片的药品注册证书2023-6-29 22:51:40
·安邦制药向湖南监管局提交的向不特定合格投资者公开发行股票并在北交所上市辅导备案申请已受理2023-6-29 21:40:29
·涛生医药控股子公司拟引入新投资者增加注册资本20.2万由深圳谷语智能科技有限公司认购2023-6-29 21:20:58
·6月29日华神科技涨停分析:中药,医药,医美概念热股2023-6-29 17:57:09
·复星医药荣登2022年度中国化药企业百强榜第6位2023-6-29 17:41:09

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]